You are here

  • Home
  • Archive
  • Volume 12, Issue 5
  • Correction: Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway

https://doi.org/10.1136/jitc-2021-004113corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Zhuo Y, Li S, Hu W, et al. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway J ImmunoTher Cancer 2022;10:e004113. doi: 10.1136/jitc-2021-004113

    This article has been corrected after publication to remove Dejia Liu from the author list. This author contacted BMJ after publication to state that they should not be listed as an author on this work because they did not read the manuscript, contribute to its contents or approve the submission. The journal corresponded with the institution and other authors regarding this, and concluded that this individual should be removed from the author list as they did not fulfil BMJ’s authorship criteria.